233 related articles for article (PubMed ID: 24106963)
1. Proteomics of the dystrophin-glycoprotein complex and dystrophinopathy.
Holland A; Carberry S; Ohlendieck K
Curr Protein Pept Sci; 2013 Dec; 14(8):680-97. PubMed ID: 24106963
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle.
Murphy S; Zweyer M; Henry M; Meleady P; Mundegar RR; Swandulla D; Ohlendieck K
J Proteomics; 2019 Jan; 191():212-227. PubMed ID: 29408692
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling of x-linked muscular dystrophy.
Lewis C; Carberry S; Ohlendieck K
J Muscle Res Cell Motil; 2009 Dec; 30(7-8):267-9. PubMed ID: 20082121
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy.
Murphy S; Dowling P; Zweyer M; Mundegar RR; Henry M; Meleady P; Swandulla D; Ohlendieck K
J Proteomics; 2016 Aug; 145():24-36. PubMed ID: 26961938
[TBL] [Abstract][Full Text] [Related]
5. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers.
Ohlendieck K
Eur J Cell Biol; 1996 Jan; 69(1):1-10. PubMed ID: 8825019
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of dystrophin-associated proteins: a common mechanism leading to muscle cell necrosis in severe childhood muscular dystrophies.
Matsumura K; Campbell KP
Neuromuscul Disord; 1993 Mar; 3(2):109-18. PubMed ID: 8358236
[TBL] [Abstract][Full Text] [Related]
7. Chemical crosslinking analysis of β-dystroglycan in dystrophin-deficient skeletal muscle.
Murphy S; Zweyer M; Mundegar RR; Swandulla D; Ohlendieck K
HRB Open Res; 2018; 1():17. PubMed ID: 35528858
[No Abstract] [Full Text] [Related]
8. Emerging proteomic biomarkers of X-linked muscular dystrophy.
Dowling P; Murphy S; Zweyer M; Raucamp M; Swandulla D; Ohlendieck K
Expert Rev Mol Diagn; 2019 Aug; 19(8):739-755. PubMed ID: 31359811
[No Abstract] [Full Text] [Related]
9. Mass spectrometric identification of dystrophin isoform Dp427 by on-membrane digestion of sarcolemma from skeletal muscle.
Lewis C; Ohlendieck K
Anal Biochem; 2010 Sep; 404(2):197-203. PubMed ID: 20507823
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling of impaired excitation-contraction coupling and abnormal calcium handling in muscular dystrophy.
Dowling P; Gargan S; Swandulla D; Ohlendieck K
Proteomics; 2022 Dec; 22(23-24):e2200003. PubMed ID: 35902360
[TBL] [Abstract][Full Text] [Related]
11. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
Matsumura K; Campbell KP
Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
[TBL] [Abstract][Full Text] [Related]
12. Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.
Zweyer M; Sabir H; Dowling P; Gargan S; Murphy S; Swandulla D; Ohlendieck K
Histol Histopathol; 2022 Feb; 37(2):101-116. PubMed ID: 34873679
[TBL] [Abstract][Full Text] [Related]
13. Dystrophin-associated glycoproteins: their possible roles in the pathogenesis of Duchenne muscular dystrophy.
Ervasti JM; Campbell KP
Mol Cell Biol Hum Dis Ser; 1993; 3():139-66. PubMed ID: 8111538
[TBL] [Abstract][Full Text] [Related]
14. Expression of dystrophin-associated proteins in dystrophin-positive muscle fibers (revertants) in Duchenne muscular dystrophy.
Matsumura K; Tomé FM; Collin H; Leturcq F; Jeanpierre M; Kaplan JC; Fardeau M; Campbell KP
Neuromuscul Disord; 1994 Mar; 4(2):115-20. PubMed ID: 7516752
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular Dystrophy.
Murphy S; Henry M; Meleady P; Zweyer M; Mundegar RR; Swandulla D; Ohlendieck K
Biology (Basel); 2015 Jun; 4(2):397-423. PubMed ID: 26067837
[TBL] [Abstract][Full Text] [Related]
16. Expression of the skeletal muscle dystrophin-dystroglycan complex and syntrophin-nitric oxide synthase complex is severely affected in the type 2 diabetic Goto-Kakizaki rat.
Mulvey C; Harno E; Keenan A; Ohlendieck K
Eur J Cell Biol; 2005 Nov; 84(11):867-83. PubMed ID: 16323284
[TBL] [Abstract][Full Text] [Related]
17. The biochemical and mass spectrometric profiling of the dystrophin complexome from skeletal muscle.
Murphy S; Ohlendieck K
Comput Struct Biotechnol J; 2016; 14():20-7. PubMed ID: 26793286
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin.
Murphy S; Brinkmeier H; Krautwald M; Henry M; Meleady P; Ohlendieck K
J Muscle Res Cell Motil; 2017 Apr; 38(2):251-268. PubMed ID: 28803268
[TBL] [Abstract][Full Text] [Related]
19. The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane instability.
Mendell JR; Sahenk Z; Prior TW
J Child Neurol; 1995 Mar; 10(2):150-9. PubMed ID: 7782608
[TBL] [Abstract][Full Text] [Related]
20. Laminin abnormality in severe childhood autosomal recessive muscular dystrophy.
Yamada H; Tomé FM; Higuchi I; Kawai H; Azibi K; Chaouch M; Roberds SL; Tanaka T; Fujita S; Mitsui T
Lab Invest; 1995 Jun; 72(6):715-22. PubMed ID: 7783429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
